Notice: This company has been marked as potentially delisted and may not be actively trading. Shockwave Medical (SWAV) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSustainabilityTrends Get the Latest News and Ratings for SWAV and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Shockwave Medical and its competitors. Enter your email to sign up for newsletter Sign Up SWAV Analyst Ratings Over TimeTypeCurrent Forecast11/23/23 to 11/22/241 Month Ago10/24/23 to 10/23/243 Months Ago8/25/23 to 8/24/241 Year Ago11/23/22 to 11/23/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy1 Buy rating(s)1 Buy rating(s)1 Buy rating(s)8 Buy rating(s)Hold9 Hold rating(s)9 Hold rating(s)10 Hold rating(s)2 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$320.50$320.50$309.11$269.78Forecasted Upside-4.26% Downside-4.26% Downside-7.66% Downside55.01% UpsideConsensus RatingHoldHoldHoldModerate Buy Central Bank Abandons USD (Ad)You know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD! Get Your FREE Gold Investor Kit NOW! SWAV Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History SWAV Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Shockwave Medical Stock vs. The CompetitionTypeShockwave MedicalMedical CompaniesS&P 500Consensus Rating Score 2.10 2.80 2.50Consensus RatingHoldModerate BuyModerate BuyPredicted Upside-4.26% Downside26,677.73% Upside8.51% UpsideNews Sentiment RatingNeutral NewsSee Recent SWAV NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails4/8/2024Leerink Partners1 of 5 stars Reiterated RatingOutperform ➝ Market Perform$361.00 ➝ $335.00+2.79%4/8/2024CL King3 of 5 stars Reiterated RatingBuy ➝ Neutral4/8/2024Deutsche Bank Aktiengesellschaft3 of 5 stars Reiterated RatingBuy ➝ Hold$270.00 ➝ $335.00+2.67%4/8/2024Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingOverweight ➝ Equal Weight$285.00 ➝ $335.00+2.65%4/5/2024Leerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. KratkySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform4/5/2024Canaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Hold$263.00 ➝ $335.00+2.51% Get the Latest News and Ratings for SWAV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. 4/5/2024Needham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Hold4/5/2024Wolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingOutperform ➝ Peer Perform4/2/2024Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$290.00 ➝ $360.00+12.32%2/16/2024Wells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetEqual Weight ➝ Equal Weight$200.00 ➝ $210.00-20.74%9/29/2023UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageNeutral$218.00+6.11%5/9/2023VNET GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingMaintains4/11/2023Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy$235.00 ➝ $275.00+21.20%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:14 AM ET. SWAV Forecast - Frequently Asked Questions What is Shockwave Medical's forecast for 2025? According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Shockwave Medical is $320.50, with a high forecast of $368.00 and a low forecast of $210.00. Should I buy or sell Shockwave Medical stock right now? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 9 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SWAV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SWAV, but not buy additional shares or sell existing shares. Does Shockwave Medical's stock price have much downside? According to analysts, Shockwave Medical's stock has a predicted downside of -4.26% based on their 12-month stock forecasts. Do Wall Street analysts like Shockwave Medical more than its competitors? Analysts like Shockwave Medical less than other "medical" companies. The consensus rating for Shockwave Medical is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SWAV compares to other companies. Stock Forecasts and Research Tools Related Companies RMD Stock Forecast DXCM Stock Forecast WST Stock Forecast PODD Stock Forecast BAX Stock Forecast SOLV Stock Forecast GMED Stock Forecast PEN Stock Forecast TFX Stock Forecast GKOS Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Central Bank Abandons USD (Ad)You know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD! Get Your FREE Gold Investor Kit NOW! This page (NASDAQ:SWAV) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shockwave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shockwave Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
